These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4016034)

  • 1. Quantitation of vaginal discharge in healthy volunteers.
    Godley MJ
    Br J Obstet Gynaecol; 1985 Jul; 92(7):739-42. PubMed ID: 4016034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrolytes in vaginal fluid during the menstrual cycle of coitally active and inactive women.
    Wagner G; Levin RJ
    J Reprod Fertil; 1980 Sep; 60(1):17-27. PubMed ID: 7431318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urea kinetics in healthy young women: minimal effect of stage of menstrual cycle, contraceptive pill and protein intake.
    McClelland IS; Jackson AA
    Br J Nutr; 1996 Aug; 76(2):199-209. PubMed ID: 8813895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
    Alvarez F; Faundes A; Johansson E; Coutinho E
    Fertil Steril; 1983 Jul; 40(1):120-3. PubMed ID: 6407876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in insulin receptors during oral contraception.
    De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
    J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vaginal contraceptive pill.
    Coutinho E
    IPPF Med Bull; 1985 Feb; 19(1):2-3. PubMed ID: 12339969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study.
    Cameron ST; Berger C; Michie L; Klipping C; Gemzell-Danielsson K
    Hum Reprod; 2015 Jul; 30(7):1566-72. PubMed ID: 25994664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception.
    Edelman AB; Gallo MF; Jensen JT; Nichols MD; Schulz KF; Grimes DA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004695. PubMed ID: 16034942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conception control by vaginal administration of pills containing ethinyl estradiol and dl-norgestrel.
    Coutinho EM; da Silva AR; Carreira C; Rodrigues V; Gonçalves MT
    Fertil Steril; 1984 Sep; 42(3):478-81. PubMed ID: 6381103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference period analysis of vaginal bleeding with triphasic oral contraceptive agents containing norethindrone or levonorgestrel: a comparison study.
    Schwarz BE; Pierce C; Walden CE; Knopp RH
    Int J Fertil; 1992; 37(3):176-82. PubMed ID: 1355765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal pH effects caused by OCs and various copper and inert IUDs.
    Kandil O; Hassanein MK; El-tagi A; El-shirbini MT
    Contracept Deliv Syst; 1983 Jul; 4(3):187-93. PubMed ID: 12265361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a low-dose progestagen as a contraceptive.
    Iizuka R; Hayashi M; Kamouchi Y; Yamanaka K
    Nihon Funin Gakkai Zasshi; 1971; 16(1):68-82. PubMed ID: 12158578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of menstrual hygiene (tampons vs pads) and of the form of contraception on pH and bacterial infection of the vagina].
    Loch EG; Kaiser E
    Fortschr Med; 1977 Nov; 95(44):2653-6, 2670. PubMed ID: 21836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during menstrual cycles controlled by oral contraceptive preparations.
    Johnson IR
    Br J Obstet Gynaecol; 1980 Oct; 87(10):883-8. PubMed ID: 7000163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of oral contraceptives on plasma cortisol and cortisol binding capacity throughout the menstrual cycle in normal women.
    Durber SM; Lawson J; Daly JR
    Br J Obstet Gynaecol; 1976 Oct; 83(10):814-8. PubMed ID: 791349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.